We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 10. | 장 마감 후 (AMC) | $-0.12 | — | — | $9.45M | — | 예정 |
Consensus PT $12.75 · 4 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 02. 19. | Roth Capital | — | 커버리지 개시 | — → Buy | — | Roth Capital: Buy |
| 2025. 04. 08. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
표시할 보유 데이터가 없습니다.
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
Stored first · Google News · Yahoo Finance (English)
BioHarvest Sciences (BHST) schedules 2026 AGM to elect board and ratify auditor - Stock Titan
BioHarvest Sciences (BHST) schedules 2026 AGM to elect board and ratify auditor Stock Titan
BioHarvest (BHST) Q4 2025 Earnings Transcript - The Globe and Mail
BioHarvest (BHST) Q4 2025 Earnings Transcript The Globe and Mail
BioHarvest Sciences and Tate & Lyle expand sweetener development program - Yahoo! Finance Canada
BioHarvest Sciences and Tate & Lyle expand sweetener development program Yahoo! Finance Canada
BioHarvest Sciences and Tate & Lyle expand sweetener development program
Tate & Lyle expands next-gen sweetener program with BioHarvest Sciences - FoodProcessing.com.au
Tate & Lyle expands next-gen sweetener program with BioHarvest Sciences FoodProcessing.com.au
BioHarvest (BHST) Q1 2026 Earnings Transcript